Deloitte insights covers Pfizer Australia's
partnership with Complexica for the deployment of its
What-if Simulator & Optimiser, powered by Larry, the Digital Analyst® which can test and optimise a variety of complex what-if scenarios based on large internal and external data sets. Moreover, the AI platform allows users to:
Business leaders in pharma and life sciences have more specific business intelligence needs than peers in other industries. In addition to common business drivers like marketing, profit and loss, and customer churn, pharmaceutical companies need information regarding patients and clinical trial results. Pharmaceutical corporation Pfizer’s Australian branch chose Complexica to improve its business decision-making process. Its chosen solution was the What-If Simulator and Optimizer, which uses Larry the Digital Analyst to model sales, marketing investments, and market conditions. Marketing conditions could include a seasonal rise in demand for a certain drug or which retailers are seeing the most sales of that drug.
